Drug ID | DDPD01165 |
|
Drug Name | Ofloxacin | |
Molecular Weight | 361.3675 | |
Molecular Formula | C18H20FN3O4 | |
CAS Number | 82419-36-1 | |
SMILES | CC1COC2=C3N1C=C(C(O)=O)C(=O)C3=CC(F)=C2N1CCN(C)CC1 | |
External Links | ||
DRUGBANK | DB01165 | |
PubChem Compound | 4583 | |
PDR | 1113 | |
Drugs.com | Drugs.com Drug Page |
Property Name | Property Value | Unit | Raw Value | Raw Unit | Reference |
---|---|---|---|---|---|
Log P | -0.39 | - | -0.39 | - | HANSCH,C ET AL. (1995) |
Melting Point | 254.0 | ℃ | 254 | ℃ | PhysProp |
Water Solubility | 28300.0 | mg/L | 28.3 | mg/ml | DRUGBANK |
Property Name | Property Value | Unit | Raw Value | Raw Unit | Annotation | Reference |
---|---|---|---|---|---|---|
Bioavailability | 98.0 | % | 98 | % | DRUGBANK | |
Clearance | 0.15 | L/h/kg | 2.5 | ml/min/kg | intravenous injection, IV; human, homo sapiens; | Human Intravenous Pharmacokinetic Dataset |
Volume of Distribution | 1.6 | L/kg | 1.6 | L/kg | intravenous injection, IV; human, homo sapiens; | Human Intravenous Pharmacokinetic Dataset |
Half-life | 9.0 | h | 9 | h | DRUGBANK | Half-life | 8.9 | h | 8.9 | h | intravenous injection, IV; human, homo sapiens; | Human Intravenous Pharmacokinetic Dataset |
Toxicity LD50 | 5450.0 | mg/kg | 5450.0 | mg/kg | PO, oral; mouse; | DRUGBANK |
Eliminate Route | 6.0 | % | ~4-8 | % | Faeces excretion; | DRUGBANK | Eliminate Route | 72.5 | % | 65-80 | % | Urinary excretion; PO, oral; Unchanged drug; | DRUGBANK |
Protein Binding | 32.0 | % | 32 | % | DRUGBANK |
Property Name | Property Value | Unit | Raw Value | Raw Unit | Annotation | Brand Name | Component | Reference |
---|---|---|---|---|---|---|---|---|
Max dose for adults | 800.0 | mg/day | 800 | mg/day | PO, oral;intravenous injection, IV; | Ocuflox | ofloxacin | PDR |
Max dose for elderly | 800.0 | mg/day | 800 | mg/day | PO, oral;intravenous injection, IV; | Ocuflox | ofloxacin | PDR |